$INO way oversold for the pipeline and quick to market approvals of RRP and VGX-3100 in the next 1-2 years. Regeneron eyeing partnership for GBM very soon. NEWS for HIV, AIN, VIN next quarter or sooner too. HIV news alone blew this stock threw the roof, that's just the tip of the iceberg now. Cash runway brings us all the way to VGX-3100 approval.